CI
UTHR icon

Cigna Investments’s United Therapeutics UTHR Stock Holding History

Cigna Investments’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$212K Hold
391
– – 0.03% 460
2026
Q1 		$232K Sell
391
-23
-6% -$11.5K 0.04% 413
2025
Q4 		$201K Buy
+414
New +$193K 0.03% 452
2022
Q1 		– Sell
-1,026
Closed -$223K – 660
2021
Q4 		$223K Sell
1,026
-460
-31% -$90.3K 0.02% 601
2021
Q3 		$273K Buy
1,486
+100
+7% +$19.7K 0.02% 587
2021
Q2 		$249K Sell
1,386
-200
-13% -$38.1K 0.02% 637
2021
Q1 		$265K Sell
1,586
-71
-4% -$11.8K 0.02% 636
2020
Q4 		$251K Buy
+1,657
New +$217K 0.02% 619
2020
Q3 		– Sell
-2,270
Closed -$274K – 762
2020
Q2 		$274K Buy
+2,270
New +$255K 0.03% 576
2019
Q2 		– Sell
-2,257
Closed -$264K – 713
2019
Q1 		$264K Buy
+2,257
New +$263K 0.03% 568
2018
Q1 		– Sell
-1,665
Closed -$246K – 896
2017
Q4 		$246K Sell
1,665
-100
-6% -$12.7K 0.02% 771
2017
Q3 		$207K Sell
1,765
-41
-2% -$5.24K 0.01% 828
2017
Q2 		$234K Sell
1,806
-100
-5% -$12.5K 0.02% 720
2017
Q1 		$258K Buy
1,906
+258
+16% +$39.1K 0.02% 632
2016
Q4 		$236K Buy
+1,648
New +$210K 0.03% 630

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Cigna Investments's UTHR Position: Q2 2026 in Review

Cigna Investments held its United Therapeutics (UTHR) position steady in Q2 2026 at 391 shares worth $212K. The position accounts for 0.03% of the portfolio, ranked #460.

Cigna Investments first reported a position in UTHR in Q4 2016 and has held it in 15 quarters since. The position peaked at $274K in Q2 2020. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Cigna Investments held 391 shares of United Therapeutics worth $212K as of Q2 2026.
  • Cigna Investments left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up 0.03% of Cigna Investments's portfolio in Q2 2026, its #460 holding.
  • Cigna Investments first reported a position in United Therapeutics in Q4 2016 and has held it in 15 quarters since.
  • Cigna Investments's United Therapeutics position peaked at $274K in Q2 2020.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.